Sabin-Based Inactivated Poliomyelitis Vaccine (sIPV)
IPV-102
Phase 2 mab terminated
Quick answer
Sabin-Based Inactivated Poliomyelitis Vaccine (sIPV) for Poliomyelitis is a Phase 2 program (mab) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Poliomyelitis
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated